Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial (Nature Medicine, (2023), 29, 3, (588-592), 10.1038/s41591-022-02199-y)
van Dorp, Jeroen; Pipinikas, Christodoulos; Suelmann, Britt B M; Mehra, Niven; van Dijk, Nick; Marsico, Giovanni; van Montfoort, Maurits L; Hackinger, Sophie; Braaf, Linde M; Amarante, Tauanne; van Steenis, Charlaine; McLay, Kirsten; Daletzakis, Antonios; van den Broek, Daan; van de Kamp, Maaike W; Hendricksen, Kees; de Feijter, Jeantine M; Boellaard, Thierry N; Meijer, Richard P; van der Heijden, Antoine G; Rosenfeld, Nitzan; van Rhijn, Bas W G; Jones, Greg; van der Heijden, Michiel S
(2024) Nature Medicine, volume 30, issue 1, pp.
(Comment)
Abstract
Correction to: Nature Medicine. Published online 2 February 2023. In the version of this article initially published, the first name of Antoine G. van der Heijden was misspelled as “Toine” and has now been corrected in the HTML and PDF versions of the article.
show less
Download/Full Text
Keywords: General Biochemistry,Genetics and Molecular Biology, Published Erratum
ISSN: 1078-8956
Publisher: Nature Publishing Group
Note: Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer Nature America, Inc.
(Peer reviewed)
